Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2025 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2025 Earnings Call Transcript November 10, 2025Inovio Pharmaceuticals, Inc. misses on earnings expectations.
Inovio Pharmaceuticals Inc. (INO)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Adage Capital Management Phill Gross And Robert Atchinson | 2,553,571 | $4,443,214 | -26% | 0.01% |
| 2. | Boxer Capital Aaron Davis And Christopher Fuglesang | 2,420,122 | $4,211,012 | +6% | 0.92% |
| 3. | D E Shaw D. E. Shaw | 2,231,811 | $3,883,351 | +177% | 0% |
| 4. | ADAR1 Capital Management Daniel Schneeberger | 1,485,008 | $2,583,914 | 0.19% | |
| 5. | Millennium Management Israel Englander | 1,403,379 | $2,441,879 | -29% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.11 | 22,500 | $69,975.00 | 1,100,707 | 2020-01-13 | Filing | |
| $2.22 | 4,500 | $9,990.00 | 50,333 | 2019-08-30 | Filing | |
| $2.50 | 20,000 | $50,000.00 | 45,833 | 2019-06-05 | Filing | |
| $6.25 | 21,300 | $133,188.90 | 50,000 | 2017-03-27 | Filing | |
| $9.13 | 10,000 | $91,309.00 | 142,291 | 2016-06-28 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.56 | 5,700 | $3,192.00 | 52,716 | 2023-06-05 | Filing | |
| $1.15 | 5,833 | $6,707.95 | 910,124 | 2023-03-13 | Filing | |
| $1.28 | 11,668 | $14,935.04 | 904,291 | 2023-02-27 | Filing | |
| $2.66 | 11,875 | $31,587.50 | 892,625 | 2022-08-11 | Filing | |
| $2.25 | 2,000 | $4,500.00 | 75,305 | 2022-07-20 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,846,664 | $17,133,195 | 0% | |
| 2. | 3,308,406 | $5,773,168 | 0% | |
| 3. | 3,315,580 | $5,769,110 | 0% | |
| 4. | 769,356 | $1,339,699 | 0% | |
| 5. | 617,869 | $1,075,092 | 0% |
News See All
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Second Quarter 2025 Financial Results Conference Call.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2025 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio First Quarter 2025 Financial Results Conference Call. At this time all participants are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Pharmaceuticals Fourth Quarter 2024 Financial Results Conference Call. At this time, all lines are in listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the Inovio Third Quarter 2024 Financial Results Conference Call. At this time, all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2024 Earnings Call Transcript
Operator: Good afternoon ladies and gentlemen and welcome to the Inovio Second Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q1 2024 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen, and welcome to the INOVIO First Quarter 2024 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q4 2023 Earnings Call Transcript
Inovio Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $-1.12, expectations were $-1.58. Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q3 2023 Earnings Call Transcript
Operator: Good afternoon, ladies and gentlemen and welcome to the Inovio Third Quarter 2023 Financial Results Conference Call. At this time all lines are in a listen-only mode.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Q2 2023 Earnings Call Transcript
Operator: Good day, and welcome to the Inovio Second Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode.
Hedge Fund Resource Center Billionaire Hedge Funds
